Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Factors for Rituximab Refractoriness in AQP4‐IgG+ NMOSD: A Cohort Study
Factors for Rituximab Refractoriness in AQP4‐IgG+ NMOSD: A Cohort Study
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Mariano Marrodan
,
María A. Piedrabuena
,
María A. Zarate
,
Sofía Rodríguez Murúa
,
Ezequiel I. Surace
,
Mauricio F. Farez
,
Marcela P. Fiol
,
María C. Ysrraelit
,
Jorge Correale
Format:
Artículo Open Access
Published:
Wiley
2025
Subjects:
Annals of Clinical and Translational Neurology
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Be the first to leave a comment!
Your Comment
You must be logged in first
Similar Items
Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4 ‐ IgG ‐Positive NMOSD
by: Jie Lin, et al.
Published: (2026)
Asymptomatic spinal lesions in patients with AQP4‐IgG‐positive NMOSD: A real‐world cohort study
by: Shugang Cao, et al.
Published: (2024)
Evaluation of the Efficacy and Safety of Satralizumab in a Pregnant NMOSD Patient With AQP4 / MOG ‐ IgG Dual Seropositive: A Case Report
by: Yeting Luo, et al.
Published: (2025)
Cognitive and Patient‐Reported Outcome Measures in LGI‐1‐IgG Autoimmune Encephalitis
by: Tatchaporn Ongphichetmetha, et al.
Published: (2025)
Identification of fibrinogen as a plasma protein binding partner for lecanemab biosimilar IgG
by: Jean‐Pierre Bellier, et al.
Published: (2024)